CD274 and neoplasm: Conversely, the expression of programmed death-ligand 1 (PD-L1) on tumor and immune cells, which aids tumors in evading immune attacks, has been linked to clinical outcomes and may make tumors amenable to immune checkpoint inhibitor therapy [140,192,193,194,195].